Siren Biotechnology and RISE Robotics emerged as the standout winners at the Superpowers for Good Live Pitch Q2 2025, showcasing their groundbreaking contributions to healthcare and industrial sustainability. Dr. Nicole Paulk, CEO of Siren Biotechnology, received the SuperCrowd Award for her company's novel cancer therapies, while Hiten Sonpal, CEO of RISE Robotics, was honored with the Judges' Choice Award for his firm's innovative approach to reducing energy consumption in heavy machinery.
The event, hosted by The Super Crowd, Inc., brought together a global audience and a panel of expert judges to evaluate four promising startups. Siren Biotechnology's focus on targeted, less toxic cancer treatments and RISE Robotics' electromechanical actuator technology, which replaces traditional hydraulic systems, were particularly lauded for their potential to address significant challenges in their respective fields.
Devin Thorpe, founder of The Super Crowd, Inc., emphasized the importance of the awards in recognizing entrepreneurs who combine innovation with social impact. The winners received a comprehensive prize package designed to support their growth, including marketing strategy consultations, capital-raising advice, and tools for investor intelligence and compliance.
The Superpowers for Good Live Pitch continues to serve as a vital platform for high-impact founders, with past participants achieving notable success in fundraising. The next edition of the event is scheduled for late September 2025, offering another opportunity for entrepreneurs to showcase their solutions for global challenges.
